For laboratory research use only. Not for human or animal use.

Orforglipron Capsules

$189.99

Orforglipron is a small-molecule, non-peptide GLP-1 receptor agonist. These capsules are labeled at 6 mg each, with 60 capsules in every bottle, and are offered for laboratory research only.

Out of stock

For laboratory research use only

Not for human or animal use. Not for therapeutic or diagnostic applications.

SKU: RR-CAPS-Orforglipron-6MG Category:

Description

A GLP-1 receptor agonist that is not a peptide

Nearly every compound that activates the GLP-1 receptor is a peptide, which makes orforglipron unusual. It is a synthetic small molecule designed to bind and activate the same receptor without the peptide backbone. That difference changes how the compound behaves in chemical terms, including its stability and how it can be packaged, and it is why a capsule format makes practical sense for this listing.

Why researchers study it

Small-molecule agonists of class B G-protein-coupled receptors were long considered difficult to design, because the natural peptide ligands make extensive contact with the receptor. Orforglipron has drawn interest as an example of how that challenge has been approached. Laboratory and preclinical work has examined its binding at the GLP-1 receptor, the signaling pathways it activates, and how its profile compares with peptide agonists in cell and animal models of glucose regulation.

Key facts

  • Format: capsules in a sealed bottle
  • Labeled quantity: 6 mg per capsule
  • Count: 60 capsules
  • Compound type: non-peptide small molecule; GLP-1 receptor agonist

Comparing with peptide agonists

Researchers who want to compare a small molecule with peptides acting at the same receptor can use our GLP-1 vials, the single-receptor incretin-class research peptide offered from 5 to 30 mg. Our GLP-2 (dual) and GLP-3 (triple) agonists extend the comparison to multi-receptor compounds.

Storage

Keep the bottle closed and store it somewhere cool, away from heat, light and humidity.

As with any receptor agonist, the comparison that interests most labs is not just whether the compound activates the target, but how: which downstream pathways it favors, and how that pattern differs from the natural hormone. Orforglipron is a useful case study for that question.

Certificates for each lot

We have each lot of orforglipron analyzed by a third-party laboratory. The certificate is posted under COA / Lab Reports, so you can confirm identity and purity against the lot printed on your bottle.

This is a research compound, available for laboratory study only.